SEC Form 5 · accession 0001209191-17-010013
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Delaney
Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 13, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | holding | — | — | — | 39,742 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4,F2 | — | holding | — | — | — | — | — | Common Shares | 12,569 | 12,569 | D |
Explanation of responses
- F1Includes 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 4,254 of these restricted stock units vest in full on May 15, 2018 after a three-year "cliff" vesting period and 5,678 of these restricted stock units vest in full on May 15, 2017.
- F2No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F3The reporting person holds previously reported options to buy 12,569 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 22, 2007 and August 20, 2008, at exercise prices between $23.71 to $25.79 per share, will expire between August 22, 2017 and August 20, 2018, and became exercisable between September 30, 2008 and September 30, 2012.
- F4The current balance reflects the expiration of 4,000 options on March 8, 2016.